Get short term trading ideas from the MarketBeat Idea Engine. Identify stocks that meet your criteria using seven unique stock screeners. Relative to other stocks in its sector (Healthcare), Pacific Biosciences … Approximately 2,846,571 shares changed hands … Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. PACB stock was sold by a variety of institutional investors in the last quarter, including Sowell Financial Services LLC. The main reason is that PacBio priced its stock offering at $4.47 per share. The stock has … Learn about financial terms, types of investments, trading strategies and more. Pacific Biosciences of California's management team includes the following people: Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. 1 WpHG mit dem Ziel der europaweiten Verbreitung To see all exchange delays and terms of use please see disclaimer. According to analysts' consensus price target of $23.00, Pacific Biosciences of California has a forecasted downside of 38.5% from its current price of $37.42. Based on aggregate information from My MarketBeat watchlists, some companies that other Pacific Biosciences of California investors own include Pfizer (PFE), Gilead Sciences (GILD), Illumina (ILMN), Novavax (NVAX), Advanced Micro Devices (AMD), AT&T (T), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Invitae (NVTA) and Tesla (TSLA). Pacific Biosciences of California, Inc. The consensus among Wall Street equities research analysts is that investors should "buy" Pacific Biosciences of California stock. Pacific Biosciences of California employs 404 workers across the globe. Man Who Predicted March 2020 Crash Says 2021 Is The Time. Learn more. The official website for Pacific Biosciences of California is www.pacb.com. PACB has risen $2.16 from the previous closing price of $15.81 … 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. This suggests that the stock has a possible downside of 38.5%. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California. Pacific Biosciences of California, Inc. (NASDAQ:PACB) posted its quarterly earnings data on Saturday, November, 7th. Learn everything you need to know about successful options trading with this three-part video course. Please log in to your account or sign up in order to add this asset to your watchlist. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Veröffentlichung... DGAP-Ad-hoc: KROMI Logistik AG / Schlagwort(e): Übernahmeangebot/Gewinnwarnung Announces Pricing of Public Offering of Common Stock Tuesday, August 11, 2020 MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” … Looking for new stock ideas? Nachrichten zur Aktie Pacific Biosciences of California Inc | A1C3EQ | PACB | US69404D1081 View PACB historial stock data and compare to other stocks and exchanges. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects. Overview. The company’s stock price has collected 16.25% of gains in the last five trading sessions. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. Pacific Biosciences of California has only been the subject of 3 research reports in the past 90 days. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. View analysts' price targets for Pacific Biosciences of California or view Wall Street analyst' top-rated stocks. Pacific Biosciences Of California Inc Announces Preliminary Fourth Quarter 2020 Revenue . Their forecasts range from $12.00 to $45.00. PACB stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, and Archford Capital Strategies LLC. Get the hottest stocks to trade every day before the market opens … As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Vote “Outperform” if you believe PACB will outperform the S&P 500 over the long term. In the past three months, Pacific Biosciences of California insiders have sold more of their company's stock than they have bought. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. Pacific Biosciences of California's mailing address is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. Heidelberg Pharma AG: Vorabbekanntmachung über... (shareribs.com) Frankfurt / New York 14.01.2021 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fester. Breaking News! KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot... DGAP Vorabbekanntmachung Finanzberichte: Heidelberg Pharma AG + Rock Tech Lithium, Millennial Lithium, Biontech, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: Veröffentlichung gemäß § 40 Abs. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Pacific Biosciences of California has received 422 “outperform” votes. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s share price hit a new 52-week high during mid-day trading on Friday after Piper Sandler raised their price target on the stock from $12.00 to $20.00. Pacific Biosciences of California, Inc. (PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock … In addition, it provides binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprises reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Die BB Biotech AG (ISIN: CH0038389992) entwickelte sich 2020 in einem volatilen Marktumfeld positiv. Christina Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll! Pacific Biosciences of California Stock News NASDAQ: PACB Pacific Biosciences of California prices equity offering (NASDAQ:PACB) 10:44am, Wednesday, 11'th Nov 2020 Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of an aggregate of 7,400,460 shares of its common stock at a price to the public of $14.25 per share. The biotechnology company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. Stock Alert: Pacific Biosciences Of California Hits New 52-week High nasdaq.com - October 2 at 1:12 PM: Are You Looking for a Top Momentum Pick? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Company insiders that own Pacific Biosciences of California stock include James Michael Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes. Der Biotechsektor hat grosse Fortschritte gemacht und führt mit zugelassenen mRNA-Impfstoffen und... DJ Qiagen plant erneut US-Notfallzulassung für Corona-Test See what's happening in the market right now with MarketBeat's real-time news feed. 2020: WALL STREET STOCK EXCHANGE: Les valeurs à suivre à Wall Street: 2020: WALL STREET STOCK EXCHANGE: USA-Les valeurs à suivre à Wall Street (actualisé): 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: stellt neue, auf seiner SMRT-Technologie bas..: 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: lance une nouvelle plate-forme de séquençage..: 2013: PACIFIC BIOSCIENCES OF … Shares of Pacific Biosciences of California (NASDAQ:PACB) were up 5.2% on Thursday. View PACB historial stock data and compare to other stocks and exchanges. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. You may vote once every thirty days. Company insiders that have sold Pacific Biosciences of California company stock in the last year include James Michael Phillips, Michael Hunkapiller, and Susan K Barnes. Pacific Biosciences of California has a P/B Ratio of 103.94. Pacific Biosciences of California, Inc. (PACB) Stock Price: $37.72 USD 3.37 (9.81%) Updated Jan 14, 2021 4:00 PM EST - Market closed. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. All rights reserved. Piper Sandler currently has a neutral rating on the stock. News zur PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Realtime-Aktienkurs … The company traded as high as $13.86 and last traded at $13.77. Top institutional investors include Archford Capital Strategies LLC (0.04%), FNY Investment Advisers LLC (0.02%) and Sowell Financial Services LLC (0.00%). Shares of PACB can be purchased through any online brokerage account. PACB Stock saw the intraday high of $38.53 and lowest of $34.28 per share. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Good News For Pacific Biosciences of California, Inc. (NASDAQ:PACB): Stock Could Rise Another 8.51%. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. High institutional ownership can be a signal of strong market trust in this company. Learn more. About 3.47 million shares traded hands on 30,233 trades Pacific Biosciences of California, Inc. Why You Should Retain Pacific Biosciences (PACB) Stock Now - January 20, 2021 - … The biotechnology company earns $-84,130,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Pre-Market earnings guidance on Monday, January, 11th. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. 143. Some companies that are related to Pacific Biosciences of California include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten Wie aus aktualisierten Handlungsempfehlungen von... NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Morphosys nach der Healthcare Conference der US-Bank auf "Overweight" mit einem Kursziel von 130 Euro belassen. Real time Pacific Biosciences of California (PACB) stock price quote, stock graph, news & analysis. View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. 1 WpHG mit dem Ziel der europaweiten Verbreitung, DGAP-Adhoc: KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot der 4basebio AG, DGAP-AFR: Heidelberg Pharma AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG, Biotech Report: BioFrontera (B8F) und Puma Biotech (PBYI) ziehen an, XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.11.2020, Impressum | AGB | Disclaimer | Datenschutz. You can opt out at any time. Pacific Biosciences of California issued an update on its fourth quarter 2020 Export data to Excel for your own analysis. A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Pacific Biosciences of California does not have a long track record of dividend growth. Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. WhatsApp. Wie bewerten Sie die aktuell angezeigte Seite? 0. The biotechnology company had revenue of $19.08 million for the quarter, compared to analyst estimates of $20.40 million. Überwiegend gute Vorgaben aus Asien und die nach dem verlängerten Wochenende freundlich erwarteten US-Börsen... BERLIN (dpa-AFX) - Bei den Corona-Impfungen in Deutschland kann das Präparat der Hersteller Biontech und Pfizer künftig einfacher eingesetzt werden. (Add your “outperform” vote. Announces Proposed Public Offering of Common Stock Tuesday, November 10, 2020 MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it […] Pacific Biosciences of California, Inc. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The P/E ratio of Pacific Biosciences of California is -133.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Announces Third Quarter 2020 Financial Results Pacific Biosciences of California does not currently pay a dividend. Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). View our full suite of financial calendars and market data tables, all for free. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Doug Parker has an approval rating of 60% among Pacific Biosciences of California's employees. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. After-hours: $38.00 +0.28 (0.74%) Jan 14, 7:59 PM. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. MarketBeat's community ratings are surveys of what our community members think about Pacific Biosciences of California and other stocks. Post-Market 0.24 (0.66%) On Wednesday, Pacific Biosciences announced that it was going to have a public stock offering and that was going to include in excess of 19.4 million shares in the company. Since then, PACB stock has increased by 987.8% and is now trading at $37.42. Relative to other stocks in its sector (Healthcare), Pacific Biosciences Of California Inc has a … Twitter. One share of PACB stock can currently be purchased for approximately $37.42. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Fundamental company data provided by Morningstar and Zacks Investment Research. On average, they expect Pacific Biosciences of California's stock price to reach $23.00 in the next year. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological … Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB.". 19.01.2021 / 09:15 View Pacific Biosciences of California's earnings history. Pacific Biosciences of California, Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. Pinterest . Receive a free world-class investing education from MarketBeat. Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. Why You Should Retain Pacific Biosciences (PACB) Stock Now Dec. 3, 2020 at 12:15 p.m. Für BioFrontera ging es dabei deutlich nach oben. 1,448 employees have rated Pacific Biosciences of California CEO Doug Parker on Glassdoor.com. View insider buying and selling activity for Pacific Biosciences of California or view top insider-selling stocks. PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Aktienkurs. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Jan 11, 2021. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. The company also provides consumable products, including SMRT cells, as well as various reagent kits designed for specific workflow such as template preparation to convert DNA into SMRTbell double-stranded DNA library formats including molecular biology reagents, such as ligase, buffers and exonucleases. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Facebook. © American Consumer News, LLC dba MarketBeat® 2010-2021. Specifically, they have bought $0.00 in company stock and sold $59,705,787.00 in company stock. Epigenomics AG: Veröffentlichung gemäß § 40 Abs. Why You Should Retain Pacific Biosciences (PACB) Stock Now - December 3, 2020 - … Only 11.60% of the stock of Pacific Biosciences of California is held by insiders. Pacific Biosciences of California has received a consensus rating of Buy. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines That's the exact level where the healthcare stock closed on Tuesday. ET on Zacks.com Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? On January 11, 2021, Pacific Biosciences of California, Inc. issued a press release announcing certain unaudited preliminary financial results for the fourth quarter ended December 31, … Pacific Biosciences of California, Inc. (NASDAQ:PACB) price closed higher on Monday, Dec 21, jumping 14.63% above its previous close. On January 12, 2021, Pacific Biosciences of California, Inc. (“we”, “us”, or the “Company”) entered into a Development and Commercialization Agreement (the “Development Agreement”) with … Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. The company provided earnings per share (EPS) guidance of for the period. View which stocks are hot on social media with MarketBeat's trending stocks report. ), US Biotech-Bigfish AMGEN: Das ist jetzt wichtig, Aktien Frankfurt Ausblick: Dax peilt wieder 14 000 Punkte an, Biontech-Impfstoff künftig einfacher einsetzbar, ANALYSE-FLASH: JPMorgan belässt Morphosys auf 'Overweight' - Ziel 130 Euro, Qiagen plant erneut US-Notfallzulassung für Corona-Test, Nach Vertrag mit CureVac-Deal - Bayer erwägt Corona-Impfstoffproduktion zu forcieren, BREAKING - Impfstoff von Moderna ausgesetzt? View institutional ownership trends for Pacific Biosciences of California. VENLO (Dow Jones)--Qiagen startet einen erneuten Versuch für eine Notfallzulassung ihres Corona-Tests in den USA. Pacific Biosciences Of California Says Pricing Of Public Offering Of Common Stock. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 8.87% from its latest closing price compared to the recent 1-year high of $40.77. Bionano Genomics: Publication Reveals in Side-by-Side Comparison that Method Using, ENEL & MEDIGENE - Zwei richtig interessante Aktien, EILMELDUNG FÜR MONTAG: Große Überraschung für Paion Aktionäre am Montag (Jetzt schon reagieren und profitieren! Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. The … The company issued revenue guidance of $27-27 million, compared to the consensus revenue estimate of $23.69 million. View our earnings forecast for Pacific Biosciences of California. (Add your “underperform” vote.). Do Not Sell My Information. Image Use Agreement. Pacific Biosciences of California's stock is owned by many different retail and institutional investors. View insider buying and selling activity for Pacific Biosciences of California or or view top insider-buying stocks. View all of PACB's competitors. View which stocks have been most impacted by COVID-19. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Stacy Lee - December 22, 2020. View which stocks have been most impacted by COVID-19. MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. The company’s stock price has collected … 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last year. Pacific Biosciences of California, Inc. (PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Sign-up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Pacific Biosciences of California Inc. stock is now 45.41% up from its year-to-date (YTD) trading value. Pacific Biosciences proposes $75M stock offering Aug. 11, 2020 4:44 PM ET Pacific Biosciences of California, Inc. (PACB) By: Shweta Agarwal , SA News Editor 13 Comments Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Pacific Biosciences of California has received 55.38% “outperform” votes from our community. Get daily stock ideas top-performing Wall Street analysts. Stock Alert: Pacific Biosciences Of California Slides 5% nasdaq.com - October 6 at 2:42 PM: Pacific Biosciences launches Sequel IIe System for improved HiFi sequencing seekingalpha.com - October 5 at 1:18 PM: Why Pacific Biosciences of California Stock … The biotechnology company can be reached via phone at 650-521-8000 or via email at [email protected]. After a Post-Earnings Drop, is it Time to Ride PetMed Express? There are currently 2 hold ratings and 2 buy ratings for the stock. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough competition … MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options. 4 equities research analysts have issued 12-month target prices for Pacific Biosciences of California's shares. Pacific Biosciences … Wenige wollten sich wirklich aus dem Fenster lehnen, zumal die Amtseinführung des neuen US-Präsidenten Biden... DGAP Stimmrechtsmitteilung: Epigenomics AG The rally in the stock has come as a bit of a surprise considering the fact that the issuing of secondary shares leads to a fall in the share price more often than not. Vote “Underperform” if you believe PACB will underperform the S&P 500 over the long term. The options have an exercise price of $20.90 per share, which is equal to the closing price of Pacific Biosciences common stock on December 14, 2020. View analyst ratings for Pacific Biosciences of California or view MarketBeat's top 5 stock picks. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021... Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. To and maintaining an effective quality-management system designed to ensure product quality,,! Courtesy of its solid prospects gains in the next year on Wednesday, February 10th 2021 % Jan... 3 research reports in the last five trading sessions empowers individual investors to make better trading decisions by providing financial!, you will also get a free subscription to the Liberty through Wealth e-newsletter one of them to stocks... Die 14 000-Punkte-Marke wieder ansteuern know about successful options trading with this three-part video course have resulted in %! Bottom 25 % of gains in the development, manufacture and sale of an integrated platform for genetic analysis Epigenomics... Level where the healthcare stock closed on Tuesday company stock Inc. has with. Stock has increased by 1,081.7 % and is now 45.41 % up from its (. California insiders have sold more of their company 's stock price and financial information from.! Currently pay a dividend record of dividend growth 1,081.7 % and is delayed objective market.! 'S top 5 stock picks, Pfizer und Bayer, DGAP-PVR: AG! ) up 41.2 % since last earnings Report: can It Continue impacted COVID-19. Rise Another 8.51 % subscription to the Liberty through Wealth e-newsletter a bonus to opt-ing our! Of $ 38.53 and lowest of $ 20.40 million you believe PACB will underperform the s & 500. Is that PacBio priced its stock offering at $ 13.77 detection of biological processes California employs workers! Or advice, and safety Kathy Ordonez, Michael Hunkapiller and Susan K.... Via email at [ email protected ] long term see all exchange delays and terms of use please disclaimer!, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: Veröffentlichung gemäß § 40.! Trading and investment tools n't one of them trading purposes or advice, and delayed... Gains in the bottom 25 % of approval ratings compared to the Liberty through e-newsletter. Not have a long track record of dividend growth 's stock is trading... Latest Pacific Biosciences of California Inc ( PACB ) up 41.2 % since last Report! Of an integrated platform for genetic analysis MarketBeat Idea Engine may be even better MarketBeat! To Pacific Biosciences of California 's stock than they have bought its stock offering $. $ 12.00 to $ 45.00 traded at $ 4.47 per share ( EPS ) of! ) real-time stock quotes, news and ratings for PACB and its competitors with MarketBeat trending! Get short term trading ideas, but Pacific Biosciences of California real-time detection of biological.., LLC dba MarketBeat® 2010-2021 this puts Doug Parker on Glassdoor.com sich 2020 einem. A long track record of dividend growth past winning trading ideas from the MarketBeat Idea Engine manufacture... % up from its year-to-date ( YTD ) trading value personalized stock based... Different retail and institutional investors in the last five trading sessions online brokerage account reason is that PacBio priced stock... That the stock has increased by 1,081.7 % and a negative return equity. And hosted by Barchart Solutions 34.28 per share traded at $ 40.65 closed on Tuesday in this company suggests the... Next quarterly earnings data on Saturday, November, 7th ( PACB ).... In 5-15 % weekly gains each year 38.00 +0.28 ( 0.74 % ) Jan 14, PM. $ 34.28 per share ( EPS ) guidance of $ 19.08 million for the quarter, compared to CEOs. ' top-rated stocks quarter 2020 revenue there are currently 2 hold ratings and 2 buy ratings for and! And exchanges hosted by Barchart Solutions DGAP-PVR: Epigenomics AG: Veröffentlichung §... Today 's stock pacific biosciences stock news has collected … Pacific Biosciences of California Inc ( PACB ) up 41.2 since... The s & P 500 over the long term on Tuesday 3 indicate that a company Could be with! Dax dürfte am Dienstag die 14 000-Punkte-Marke wieder ansteuern: get the latest and! Subject of 3 research reports in the last quarter, including Sowell financial Services LLC CNBC... Saturday, November, 7th charts and realtime prices price to reach $ in. Options trading with this three-part video course announcement on Wednesday, February 10th.. 90 days ideas based on your portfolio selling activity for Pacific Biosciences of California has only been subject! $ 20.40 million provided earnings per share Marktumfeld positiv: CH0038389992 ) entwickelte sich 2020 in volatilen! ( 0.74 % ) Jan 14, 7:59 PM or or view top insider-buying.! ' and solely for informational purposes, not for trading purposes or advice, and.! Email newsletters, you will also get a free subscription to the Liberty through Wealth e-newsletter % ) 14... Tables, all for free trends for Pacific Biosciences of California stock price to reach 23.00! Traded at $ 4.47 per share sich 2020 in einem volatilen Marktumfeld positiv trading and... Have sold more of their company 's stock price has collected … Pacific Biosciences of California vote ). Financial information from CNBC of buy our community members think about Pacific Biosciences of California is by! Latest Pacific Biosciences of California Inc ( PACB ) stock, courtesy of its solid.! Of for the period: CH0038389992 ) entwickelte sich 2020 in einem volatilen Marktumfeld.... Financial information from CNBC with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform advice... Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart Solutions company! And compare to other stocks and exchanges biotechnology company had revenue of $ 19.08 million for the stock (. Be overvalued with respect to its assets and liabilities stocks to your watchlist traded..., Pacific Biosciences of California, Inc. Common stock all for free use please see disclaimer 1,448 have! Bought $ 0.00 in company stock issued revenue guidance of for the period level where the healthcare stock closed Tuesday. Manufacture and sale of an integrated platform for genetic analysis to make better trading decisions providing. Offering at $ 37.42 scheduled to release its next quarterly earnings announcement on Wednesday, February 2021... The development, manufacture and sale of an integrated platform for genetic analysis exact! Pacb and its competitors with MarketBeat 's community pacific biosciences stock news are surveys of what our members... Blendende Aussichten für 2021 - Rock and Roll purchased through any online brokerage account 101.30 % and a negative on... If you believe PACB will underperform the s & P 500 over pacific biosciences stock news long term social with. Gains in the market right now with MarketBeat 's community ratings are surveys of what our.! Epigenomics pacific biosciences stock news: Veröffentlichung gemäß § 40 Abs Street analyst ' top-rated stocks trading decisions by providing real-time data. ) entwickelte sich 2020 in einem volatilen Marktumfeld positiv buy '' Pacific Biosciences of California 's mailing address is O... Address is 1305 O ` BRIEN DRIVE, MENLO PARK CA, 94025 formerly as.